Genmab A/S (GMAB)

Genmab Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 24, 2026	Dec 31, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
Market Capitalization	15,705	19,630	13,162	20,841	27,619	26,318
Market Cap Growth	-1.71%	49.14%	-36.85%	-24.54%	4.94%	-0.60%
Enterprise Value	19,366	16,358	10,895	16,883	24,292	23,518
Last Close Price	25.81	30.80	20.87	31.84	42.38	39.56
PE Ratio	16.31	20.38	11.62	33.03	35.26	58.19
PS Ratio	4.22	5.28	4.22	8.72	13.25	20.44
PB Ratio	2.69	3.36	2.56	4.45	7.05	7.75
P/TBV Ratio	-	-	4.31	4.46	7.08	7.84
P/FCF Ratio	13.67	17.08	11.98	20.47	53.47	87.08
P/OCF Ratio	13.24	16.55	11.69	19.46	49.14	77.23
EV/Sales Ratio	5.21	4.40	3.49	7.06	11.66	18.27
EV/EBITDA Ratio	15.01	12.68	10.36	21.05	25.79	48.86
EV/EBIT Ratio	15.49	13.09	10.73	21.87	26.98	52.07
EV/FCF Ratio	16.86	14.24	9.91	16.59	47.03	77.81
Debt / Equity Ratio	0.93	0.93	0.03	0.02	0.02	0.02
Debt / EBITDA Ratio	4.15	4.15	0.13	0.14	0.09	0.14
Debt / FCF Ratio	4.72	4.72	0.13	0.11	0.17	0.22
Net Debt / Equity Ratio	0.64	0.64	-0.55	-0.87	-0.80	-0.85
Net Debt / EBITDA Ratio	2.88	2.88	-2.67	-5.06	-3.31	-6.01
Net Debt / FCF Ratio	3.23	3.23	-2.56	-3.98	-6.04	-9.57
Asset Turnover	0.39	0.39	0.54	0.49	0.53	0.37
Inventory Turnover	17.63	17.63	16.82	-	-	-
Quick Ratio	2.01	2.01	5.23	13.33	15.48	14.50
Current Ratio	2.02	2.02	5.24	13.35	15.48	14.50
Return on Equity (ROE)	17.54%	17.54%	23.07%	14.46%	22.04%	14.31%
Return on Assets (ROA)	8.10%	8.10%	10.89%	9.96%	14.31%	8.06%
Return on Invested Capital (ROIC)	16.61%	16.82%	58.66%	83.50%	108.72%	64.65%
Return on Capital Employed (ROCE)	10.90%	10.90%	17.90%	15.90%	22.10%	12.80%
Earnings Yield	6.13%	4.91%	8.61%	3.03%	2.84%	1.72%
FCF Yield	7.32%	5.85%	8.35%	4.88%	1.87%	1.15%
Buyback Yield / Dilution	3.04%	3.04%	1.88%	0.17%	0.06%	-0.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q